Cargando…
Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation
Although hereditary kidney cancer syndrome accounts for approximately five percent of all kidney cancers, the mechanistic insight into tumor development in these rare conditions has provided the foundation for the development of molecular targeting agents currently used for sporadic kidney cancer. I...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834811/ https://www.ncbi.nlm.nih.gov/pubmed/29325224 http://dx.doi.org/10.1111/cas.13503 |